- Home
- BBNX vs NFJ Comparison
BBNX vs NFJ Comparison
Compare BBNX & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBNX | NFJ |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | BBNX | NFJ |
|---|---|---|
| Price | $14.94 | $13.49 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $29.08 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 223.5K |
| Earning Date | 02-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.01% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $88,570,000.00 | N/A |
| Revenue This Year | $53.58 | N/A |
| Revenue Next Year | $35.12 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 67.01 | N/A |
| 52 Week Low | $8.89 | $10.45 |
| 52 Week High | $32.71 | $12.86 |
Technical Indicators
Market Signals| Indicator | BBNX | NFJ |
|---|---|---|
| Relative Strength Index (RSI) | 23.93 | 64.04 |
| Support Level | $16.02 | $13.37 |
| Resistance Level | $19.03 | $13.52 |
| Average True Range (ATR) | 1.69 | 0.13 |
| MACD | -0.71 | 0.02 |
| Stochastic Oscillator | 2.37 | 81.27 |
Price Performance
Historical ComparisonAbout BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.